Citius Oncology, Inc. CTOR Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$26.61M-381% | -$5.53M-10.8% | -$5M+7.0% | -$5.37M+30.6% | -$7.74M-16.2% | ||
| $3.53M-10.9% | $3.96M+72.1% | $2.3M+8.1% | $2.13M+1.8% | $2.09M+15.5% | ||
| -$3.83M+47.9% | -$7.35M-436% | -$1.37M0.0% | -$1.37M0.0% | -$1.37M0.0% | ||
| -$600K+86.4% | -$4.4M-206% | -$1.44M0.0% | -$1.44M0.0% | -$1.44M0.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $20M— | —— | —— | ||
| —— | $15.13M+299% | $3.79M0.0% | $3.79M0.0% | $3.79M0.0% | ||
| -$4.66M-238% | $3.37M+244% | $981.2K0.0% | $981.2K0.0% | $981.2K0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Citius Oncology, Inc. generate?
- Citius Oncology, Inc. (CTOR) generated -$13.9M in operating cash flow over the trailing twelve months.
- Where does Citius Oncology, Inc.'s cash flow data come from?
- Every line is extracted from Citius Oncology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.